Raytheon Company (NYSE: RTN) and the U.S. Air Force have completed the latest in a series of successful flight tests for the HARM Control Section Modification (HCSM), the newest product in the HARM missile inventory.
An upgrade to existing HARM missiles, HCSM dramatically increases effectiveness against even the most modern enemy radar while reducing the possibility of collateral damage.
During the test mission, an F-16 aircraft fired an HCSM AGM-88F against an emitter located outside a pre-planned zone of exclusion. A similar radiating emitter within the ZOE attempted to confuse the HCSM so it would engage the decoy target. Using its new GPS/inertial measurement unit (IMU) capability, HCSM successfully impacted the correct target.
"HCSM provides the warfighter an effective, affordable solution that improves the probability of hit, defeats counter-HARM tactics and controls where the missile can and cannot fly," said Mike Jarrett, vice president of Raytheon's Air Warfare Systems.
The U.S. Air Force will make a fielding decision once the test series is complete, and declare the new HCSM capability operational. The Air Force awarded Raytheon the HCSM contract in 2012. The missile was recently cleared for full-rate production.
About HARM and HCSM
Source: Raytheon Corporation (NYSE: RTN)
Date: Oct 19, 2015